41 results
DEF 14A
COGT
Cogent Biosciences Inc
30 Apr 19
Definitive proxy
5:25pm
and related disclosures as well as critical accounting policies and practices used by us;
coordinating the oversight and reviewing the adequacy of our … on our website or in a current report on Form 8-K.
Board Leadership Structure and Board’s Role in Risk Oversight
Currently, the role of chairman
8-K
EX-99.1
COGT
Cogent Biosciences Inc
14 Jun 19
Unum Therapeutics Strengthens and Expands Leadership Team
12:00am
strategy and medical and translational oversight of the Unum portfolio. Prior to joining Unum, Dr. Sachs spent several years at Takeda/Millennium where
10-Q
yysq9z2 sk5wv
14 May 18
Quarterly report
7:01am
424B5
pgeppwyq1a k85imf
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
eypdcrpmmpk55p
30 Nov 20
Prospectus supplement for primary offering
5:28pm
S-3
EX-1.2
hu71nkourdhrs0h aos
2 Apr 19
Shelf registration
12:00am